184 related articles for article (PubMed ID: 284840)
21. [Clinical experiences with polyethylene glycol-bound E. coli L-asparaginase in patients with multiple recurrences of acute lymphoblastic leukemia].
Jürgens H; Schwamborn D; Körholz D; Wahn V; Göbel U
Klin Padiatr; 1988; 200(3):184-9. PubMed ID: 3210651
[TBL] [Abstract][Full Text] [Related]
22. Hepatic sinusoidal obstruction syndrome during maintenance therapy of childhood acute lymphoblastic leukemia is associated with continuous asparaginase therapy and mercaptopurine metabolites.
Toksvang LN; De Pietri S; Nielsen SN; Nersting J; Albertsen BK; Wehner PS; Rosthøj S; Lähteenmäki PM; Nilsson D; Nystad TA; Grell K; Frandsen TL; Schmiegelow K
Pediatr Blood Cancer; 2017 Sep; 64(9):. PubMed ID: 28423235
[TBL] [Abstract][Full Text] [Related]
23. Combination chemotherapy for bone marrow relapse in childhood lymphoblastic leukaemia (ALL).
Chessells JM; Cornbleet M
Med Pediatr Oncol; 1979; 6(4):359-65. PubMed ID: 289904
[TBL] [Abstract][Full Text] [Related]
24. Sanctuary therapy: a randomized trial of 724 children with previously untreated acute lymphoblastic leukemia: A Report from Children's Cancer Study Group.
Nesbit ME; Sather H; Robison LL; Donaldson M; Littman P; Ortega JA; Hammond GD
Cancer Res; 1982 Feb; 42(2):674-80. PubMed ID: 7034927
[TBL] [Abstract][Full Text] [Related]
25. Therapy of acute leukemia with drug combinations which include asparaginase.
Leventhal BG; Henderson ES
Cancer; 1971 Oct; 28(4):825-9. PubMed ID: 5286445
[No Abstract] [Full Text] [Related]
26. Phase II study with sequential L-asparaginase and methotrexate in advanced refractory breast cancer.
Yap HY; Benjamin RS; Blumenschein GR; Hortobagyi GN; Tashima CK; Buzdar AU; Bodey GP
Cancer Treat Rep; 1979 Jan; 63(1):77-83. PubMed ID: 369695
[TBL] [Abstract][Full Text] [Related]
27. L-Asparaginase, vincristine, and prednisone for induction of first remission in acute lymphocytic leukemia.
Ortega JA; Nesbit ME; Donaldson MH; Hittle RE; Weiner J; Karon M; Hammond D
Cancer Res; 1977 Feb; 37(2):535-40. PubMed ID: 264412
[TBL] [Abstract][Full Text] [Related]
28. The effect of asparaginase therapy on methotrexate toxicity and efficacy in children with acute lymphoblastic leukemia.
Kloos RQH; Pieters R; van den Bos C; van Eijkelenburg NKA; de Jonge R; van der Sluis IM
Leuk Lymphoma; 2019 Dec; 60(12):3002-3010. PubMed ID: 31120351
[TBL] [Abstract][Full Text] [Related]
29. Use of L-asparaginase and cytosine arabinoside for refractory acute lymphocytic leukemia with particular reference to T-cell leukemia.
Steuber CP; Levy GJ; Nix WL; Shepherd DA; Starling KA; Fernbach DJ
Med Pediatr Oncol; 1978; 5(1):33-8. PubMed ID: 311413
[TBL] [Abstract][Full Text] [Related]
30. L-Asparaginase as a single agent in acute lymphocytic leukemia: survey of studies form Childrens Cancer Study Group.
Nesbit ME; Ertel I; Hammond GD
Cancer Treat Rep; 1981; 65 Suppl 4():101-7. PubMed ID: 7049373
[TBL] [Abstract][Full Text] [Related]
31. Recurrent childhood lymphocytic leukemia: clinical and cytokinetic studies of cytosine arabinoside and methotrexate for maintenance of second hematologic remission.
Rivera G; Murphy SB; Aur RJ; Verzosa MS; Dahl GV; Mauer AM
Cancer; 1978 Dec; 42(6):2521-8. PubMed ID: 282003
[No Abstract] [Full Text] [Related]
32. Comparison of CNS-leukaemia in children with acute leukaemia, induced either with rubidomycin or L-asparaginase.
de Vaan GA; Marcar JR; Schretlen ED
Padiatr Padol; 1971; 6(3):230-9. PubMed ID: 5293526
[No Abstract] [Full Text] [Related]
33. Antimetabolite-based therapy in childhood T-cell acute lymphoblastic leukemia: a report of POG study 9296.
Winter SS; Holdsworth MT; Devidas M; Raisch DW; Chauvenet A; Ravindranath Y; Ducore JM; Amylon MD
Pediatr Blood Cancer; 2006 Feb; 46(2):179-86. PubMed ID: 16007607
[TBL] [Abstract][Full Text] [Related]
34. Prolonged methotrexate infusions in children with acute leukemia in relapse and in remission and with medulloblastoma. Pharmacokinetics, toxicity and clinical results.
Janka GE; Mack R; Helmig M; Haas RJ; Bidlingmaier F
Oncology; 1984; 41(4):225-32. PubMed ID: 6589560
[TBL] [Abstract][Full Text] [Related]
35. Favorable response to maintenance therapy of second or subsequent remissions in childhood acute lymphocytic leukemia.
Kimball JC; Herson J; Sullivan MP
Cancer; 1980 Sep; 46(5):1093-7. PubMed ID: 6938300
[TBL] [Abstract][Full Text] [Related]
36. Intermediate dose methotrexate and sequential L-asparaginase for treatment of refractory acute lymphocytic leukaemia.
Shetty PA; Kurkure PA; Dasgupta A
Indian J Cancer; 1984; 21(1):45-9. PubMed ID: 6595214
[No Abstract] [Full Text] [Related]
37. [Acute lymphoblastic leukemia in children. Long survivals obtained with protocols C2-72 and D-74 (1972-1977)].
Ortega JJ; Javier G; Montagut JM; Torán N
An Esp Pediatr; 1986 Feb; 24(2):87-97. PubMed ID: 3516041
[TBL] [Abstract][Full Text] [Related]
38. Vincristine, prednisone and L-asparaginase in the induction of remission in children with acute lymphoblastic leukemia following relapse.
Kung FH; Nythan WL; Cuttner J; Falkson G; Lanzkowsky P; Del Duca V; Nawabi IU; Koch K; Pluess H; Freeman A; Burgert EO; Leone LA; Ruymann F; Patterson RB; Degnan T; Hakami N; Pajak TF; Holland J
Cancer; 1978 Feb; 41(2):428-34. PubMed ID: 272945
[TBL] [Abstract][Full Text] [Related]
39. Asparaginase in combination chemotherapy for remission induction of childhood acute lymphocytic leukemia.
Pratt CB; Roberts D; Shanks E; Warmath EL; Jackson R
Cancer Res; 1973 Sep; 33(9):2020-5. PubMed ID: 4516498
[No Abstract] [Full Text] [Related]
40. Value of high-dose cytarabine during interval therapy of a Berlin-Frankfurt-Munster-based protocol in increased-risk children with acute lymphoblastic leukemia and lymphoblastic lymphoma: results of the European Organization for Research and Treatment of Cancer 58881 randomized phase III trial.
Millot F; Suciu S; Philippe N; Benoit Y; Mazingue F; Uyttebroeck A; Lutz P; Mechinaud F; Robert A; Boutard P; Marguerite G; Ferster A; Plouvier E; Rialland X; Behard C; Plantaz D; Dresse MF; Philippet P; Norton L; Thyss A; Dastugue N; Waterkeyn C; Vilmer E; Otten J;
J Clin Oncol; 2001 Apr; 19(7):1935-42. PubMed ID: 11283125
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
